Terms &
Conditions

By using the services of PHARMALERT, you accept the following terms and conditions as a client.

​

Unless otherwise stated, the contents of this site including text, images and videos are the property of PHARMALERT. All logos and trademarks used or referred to in this website are the property of their respective owners.

​

PHARMALERT will monitor the regulatory approvals of the molecules of interest of a client over the length of time agreed upon purchase and starting on the day the payment was received. The absence of e-mail alerts from PHARMALERT regarding a particular molecule does not imply lack of monitoring but absence of relevant events to report.

 

The accuracy and timeliness of the data supplied by PHARMALERT to its clients depends on the authorities that manage this information in each country. PHARMALERT therefore shall not be responsible nor liable for delays or inaccuracies in the information relayed from these official sources to its clients.

​

PHARMALERT relays factual data from official sources and does not make predictions of future events. Clients who use information supplied by PHARMALERT in their decision-making processes, whether for business, investment or other activities, are solely responsible for the accuracy of their predictions. PHARMALERT therefore shall not be responsible nor liable for any type of loss, financial or otherwise, resulting from the use of the data that it supplies to its clients.

 

In the unlikely event that PHARMALERT terminates the service before the agreed date, PHARMALERT will reimburse the client with an amount equivalent to the remaining months of the period purchased.